ZLAB Stock Analysis: Buy, Sell, or Hold?
ZLAB - Zai Lab Limited American Depositary Shares
$16.60
-0.65 (-3.77%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When ZLAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ZLAB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ZLAB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ZLAB is currently trading at $16.60, which is considered oversold relative to its 30-day fair value range of $17.42 to $18.81.
Technical Outlook: Technically, ZLAB is in a strong downtrend. The price is currently testing key support at $16.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: ZLAB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (22th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $47.50 (+175.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ZLAB is in a strong downtrend. The price is currently testing key support at $16.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: ZLAB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (22th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $47.50 (+175.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$17.42 -
$18.81
Company Quality Score
50/100
(HOLD)
Options IV Signal
22th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
62.5%
Protect Your Profits
Holding ZLAB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 22th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 175.3% below Wall St target ($47.50)
- CAUTION: Recommendation downgraded due to -9.4% 5-day decline
Fair Price Analysis
30-Day Fair Range
$17.42 -
$18.81
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.40
(8.5%)
Support & Resistance Levels
Support Level
$16.50
Resistance Level
$19.14
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-23.59
Wall Street Target
$47.50
(+175.3%)
Revenue Growth (YoY)
13.5%
Profit Margin
-46.8%
Last updated: January 30, 2026 11:43 PM ET
Data refreshes hourly during market hours. Next update: 12:43 AM
Data refreshes hourly during market hours. Next update: 12:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZLAB showing a specific setup today?
Insider Activity (6 Months)
1
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua L Smiley
BUY
10000 shares
2025-09-10
Joshua L Smiley
SELL
6641 shares
2025-08-18
Yajing Chen
SELL
1438 shares
2025-08-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$42 | 64 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
Advanced ZLAB Option Strategies
Professional options setups generated by AI based on today's ZLAB price and gamma walls.
